ESC 365 - Antithrombotic management of atrial fibrillation: follow-up data from the PREFER in AF registry

ESC Premium Access

Antithrombotic management of atrial fibrillation: follow-up data from the PREFER in AF registry

Session: Poster session 3 - Anticoagulation in atrial fibrillation

Topic: Atrial fibrillation (AF)

Speaker: Associate Professor G. Renda (Chieti, IT)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Associate Professor Giulia Renda

G. d Annunzio University, Chieti (Italy)

0 follower

20 more presentations in this session

Prothrombin activation fragment (F1+2) as an index of anticoagulant therapy with factor Xa inhibitor in atrial fibrillation

Speaker: Doctor E. Ueno (Kahoku, JP)

Is there a difference in treatment persistence across oral anticoagulants? Results of a UK cohort study evaluating oral anticoagulation therapy in an atrial fibrillation population

Speaker: Ms G. Stynes (Uxbridge, GB)

Is major bleeding risk for oral anticoagulants similar between non-valvular atrial fibrillation patients newly initiated on warfarin and propensity-score matched NOAC initiators? A real world study

Speaker: Professor G. Lip (Liverpool, GB)

Differences in the characteristics of patients with non-valvular atrial fibrillation who are newly prescribed apixaban, rivaroxaban, dabigatran and VKA in general practice in the UK

Speaker: Ms G. Stynes (Uxbridge, GB)

The HAS-BLED score for prediction of stroke and systemic embolism: insights from the PREvention oF thromboembolic events, European Registry in Atrial Fibrillation (PREFER in AF)

Speaker: Doctor M. Rohla (Bern, CH)

Access the full session

Poster session 3 - Anticoagulation in atrial fibrillation

Speakers: Associate Professor G. Renda, Doctor E. Ueno, Ms G. Stynes, Professor G. Lip, Ms G. Stynes...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources